RecruitingNCT07184814

Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement


Sponsor

China-Japan Friendship Hospital

Enrollment

150 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to identify the clinical features, management pattern and long-term outcomes of patients with pulmonary arteries involvement in Takayasu's arteritis (TAK-PAI).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is an observational registry study looking at the medical records of patients who have been diagnosed with Takayasu's arteritis (a rare inflammatory disease of the large blood vessels) that involves the pulmonary arteries (blood vessels of the lungs). Researchers want to understand the clinical features and long-term outcomes of this specific form of the disease. **You may be eligible if...** - You were hospitalized between January 2016 and December 2026 - You have been diagnosed with Takayasu's arteritis according to established medical criteria - Imaging confirmed involvement of the pulmonary arteries **You may NOT be eligible if...** - Your pulmonary artery disease is caused by another condition, such as a different type of vasculitis, a tumor, sarcoidosis, or chronic blood clots Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

China-Japan Friendship hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07184814


Related Trials